PetVivo Holdings, Inc. announce that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application related to the Company?s proprietary biocompatible protein-based particles. The broad scope of the issued claims in this patent, entitled ?Biocompatible Protein-Based Particles and Methods Thereof? provides protection for a broad range of proprietary products, including the biocompatible sponge-like particles used in PetVivo?s signature product, Spryng?

with OsteoCushion? Technology. With the imminent patent issuance by the USPTO, PetVivo?s intellectual property portfolio has grown to twenty allowed patents, ten of which are United States patents.

PetVivo diligently protects its proprietary technologies, including the fabricated biomaterials and their application in end products and devices. To maximize the strength and value of its intellectual property, the claims pursued by PetVivo generally cover the commercial devices/therapeutics, the manufacturing methods and the methods of use of PetVivo?s proprietary technology.